ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

NFX Nuformix Plc

0.19
-0.01 (-5.00%)
26 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Nuformix Plc LSE:NFX London Ordinary Share GB00BYW79Y38 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.01 -5.00% 0.19 0.18 0.20 - 2,652,375 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -859k -0.0012 -1.67 1.49M
Nuformix Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker NFX. The last closing price for Nuformix was 0.20p. Over the last year, Nuformix shares have traded in a share price range of 0.18p to 0.44p.

Nuformix currently has 744,309,368 shares in issue. The market capitalisation of Nuformix is £1.49 million. Nuformix has a price to earnings ratio (PE ratio) of -1.67.

Nuformix Share Discussion Threads

Showing 7451 to 7474 of 9525 messages
Chat Pages: Latest  309  308  307  306  305  304  303  302  301  300  299  298  Older
DateSubjectAuthorDiscuss
09/4/2021
10:43
From Oxilio website,Our approach to drug repurposing sets us apart from most other repurposing companies. We aim to repurpose an existing drug through optimisation of the formulation, dose and dosing regimen in order to maximise its efficacy in the new indication. Our OXL001 clinical trial programme is being designed to satisfy all aspects of drug safety and efficacy associated with optimal formulation, dose and dosing regimen of OXL001 in the treatment of cancer. The programme is informed by our advanced formulation and modelling/simulation work. We aim to take our first formulation of OXL001 into the clinic later in 2021.
georgeo1
09/4/2021
08:55
Fundraise coming lol! They only got the money from the recent one last week.
soupdragon55
09/4/2021
00:29
Holding RNS, it's a sell. Another fundraise coming i suppose
letmepass
08/4/2021
23:46
It's got to be a sell managed over days
rodrod1
08/4/2021
19:45
Outstanding. I hope that's a buy!!
for fx sake
08/4/2021
19:20
18 million buy showing

£468k over 3%

spurs90
08/4/2021
15:47
2.61p to sell at present
maytrees
08/4/2021
15:43
Some large trades and at least an offer share price gain so far.
maytrees
06/4/2021
16:53
£5 million added to market cap today.
georgeo1
30/3/2021
21:52
https://www.uk-cpi.com/investors
georgeo1
30/3/2021
18:35
Place of completion Wilton, UK Same location as in the nfx holdings rns.
georgeo1
30/3/2021
18:31
CPI .https://www.uk-cpi.com/markets/pharmaceuticals
georgeo1
30/3/2021
15:51
https://twitter.com/DbVelar/status/1373997206240428032?s=20
georgeo1
30/3/2021
13:19
One failure. Good news for Nuformix &Oxilio. https://pulmonaryfibrosisnews.com/2021/03/16/galactic-1-ipf-trial-gb0139-stopping-high-dose-limiting-low-dose-group/
georgeo1
30/3/2021
08:39
Any news on licensing could send the share price upwards it's a matter of time. Probably sorting out right now with Oxilio partnership.
georgeo1
30/3/2021
08:26
A million dumped straight off the mark. Hope that's not one of our newer investors.
for fx sake
29/3/2021
14:27
https://pharmaphorum.com/news/redx-shares-soar-after-ipf-drug-deal-with-astrazeneca/NFX IPF product inhaler big demand once on the market.jmo.
georgeo1
29/3/2021
10:55
So ...there's undisclosed amount being received here. Might be more than the placing amount.
georgeo1
29/3/2021
10:40
The Placing is conditional upon approval by shareholders of the passing of certain resolutions to be proposed at a general meeting of the Company to be held on 29 March 2021 (the "General Meeting")...pursue additional business development opportunities for NXP001 in oncology should Oxilio not exercise the option to license NXP001 in oncology. Oxilio have already done this , does that mean it's still on.
georgeo1
29/3/2021
09:20
Latest news ...results from AGM all duly passed. Whoop whoop lol.
georgeo1
26/3/2021
10:09
There is a small chance of a boost this afternoon if they get their Innovate grant.
for fx sake
26/3/2021
09:25
Am afraid it's back to 2p here, nice while it lasted , lots of shares to spread around now.
jotoha2
25/3/2021
21:46
See if NFX makes any gains on Friday towards Mondays agenda. Should be interesting to watch this space.
georgeo1
25/3/2021
07:04
See page 17 of the brokers note for a timeline of NXP002
soupdragon55
Chat Pages: Latest  309  308  307  306  305  304  303  302  301  300  299  298  Older

Your Recent History

Delayed Upgrade Clock